Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 12:13:914620.
doi: 10.3389/fmicb.2022.914620. eCollection 2022.

Nanoparticle-Based Lateral Flow Biosensor Integrated With Loop-Mediated Isothermal Amplification for Rapid and Visual Identification of Chlamydia trachomatis for Point-of-Care Use

Affiliations

Nanoparticle-Based Lateral Flow Biosensor Integrated With Loop-Mediated Isothermal Amplification for Rapid and Visual Identification of Chlamydia trachomatis for Point-of-Care Use

Xu Chen et al. Front Microbiol. .

Abstract

Chlamydial infection, caused by Chlamydia trachomatis, is the most common bacterial sexually transmitted infection and remains a major public health problem worldwide, particularly in underdeveloped regions. Developing a rapid and sensitive point-of-care (POC) testing for accurate screening of C. trachomatis infection is critical for earlier treatment to prevent transmission. In this study, a novel diagnostic assay, loop-mediated isothermal amplification integrated with gold nanoparticle-based lateral flow biosensor (LAMP-LFB), was devised and applied for diagnosis of C. trachomatis in clinical samples. A set of LAMP primers based on the ompA gene from 14 C. trachomatis serological variants (serovar A-K, L1, L2, L3) was successfully designed and used for the development of C. trachomatis-LAMP-LFB assay. The optimal reaction system can be performed at a constant temperature of 67°C for 35 min. The total assay process, including genomic DNA extraction (~15 min), LAMP reaction (35 min), and LFB readout (~2 min), could be finished within 60 min. The C. trachomatis-LAMP-LFB could detect down to 50 copies/ml, and the specificity was 100%, no cross-reactions with other pathogens were observed. Hence, our C. trachomatis-LAMP-LFB was a rapid, reliable, sensitive, cost-effective, and easy-to-operate assay, which could offer an attractive POC testing tool for chlamydial infection screening, especially in resource starvation settings.

Keywords: Chlamydia trachomatis; gold nanoparticle-based lateral flow biosensor; limit of detection; loop-mediated isothermal amplification; point-of-care testing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
C. trachomatis-LAMP-LFB workflow. C. trachomatis-LAMP-LFB assay contains three steps: genomic DNA preparation (step 1), LAMP reaction (step 2), and LFB visually readout (step 3). The whole diagnosis procedure can be completed within 60 min.
Figure 2
Figure 2
Schematic diagram of the principle of LFB for visually readout C. trachomatis-LAMP products. (A) C. trachomatis-LAMP products and (1.0 μl) and running buffer (100 μl) were simultaneously added to the sample pad. (B) The running buffer and C. trachomatis-LAMP products move forward to conjugate pad and reaction region due to capillary action. (C) For positive results, the FAM/biotin-labeled ompA-LAMP products are arrested by anti-FAM at TL strip, and the streptavidin-DPNs are arrested through biotin-BSA at CL strip. For negative results, only the streptavidin-DPNs flow to reaction region and arrested by biotin-BSA at CL strip. (D) Interpretation of the C. trachomatis-LAMP-LFB assay results: negative—only the CL appears on the LFB; positive—CL and TL appear on biosensor.
Figure 3
Figure 3
Confirmation and verification of C. trachomatis-LAMP products. C. trachomatis-LAMP products were measured simultaneously through MG regents (A) and LFB (B). Tube 1/biosensor 1: positive result for the C. trachomatis ompA standard plasmids; tube 2/biosensor 2: negative result for Neisseria gonorrhoeae; tube 3/biosensor 3: negative result for Ureaplasma urealyticum; tube 4/biosensor 4: blank control (distilled water, DW). TL, test line; CL, control line.
Figure 4
Figure 4
Optimization of the temperature for C. trachomatis-LAMP reactions. C. trachomatis-LAMP reaction process was monitored using real-time turbidity (LA-500). The threshold value was 0.1, and the turbidity >0.1 was regarded as positive. Eight kinetic graphs (A–H) were yielded at various amplification temperatures (63–70°C at 1°C intervals) with C. trachomatis ompA-plasmids at the level of 5 × 103 copies/ml. The graphs at 67°C showed robust amplification.
Figure 5
Figure 5
Assay sensitivity using serially diluted C. trachomatis ompA-plasmid templates. (A) Visual MG regents used for detecting the results; (B) LFB used for detecting the results. Tubes A1–A7 (biosensors B1–B7) represent the C. trachomatis ompA-plasmid levels of 5.0 × 104, 5.0 × 103, 5.0 × 102, 5.0 × 101, 5.0 × 100, 5.0 × 10−1, and 5.0 × 10−2 copies/ml and blank control (distilled water). The template levels from 5.0 × 104 to 5.0 × 101 copies/ml showed positive results. CL, control line; TL, test line.
Figure 6
Figure 6
Optimization of reaction time for C. trachomatis-LAMP-LFB assay. Reaction times (A, 15 min; B, 25 min; C, 35 min; D, 45 min) were tested at optimal reaction temperature of 67°C. Tube/biosensors B1–B7 represent plasmid levels of 5.0 × 104, 5.0 × 103, 5.0 × 102, 5.0 × 101, 5.0 × 100, 5.0 × 10−1, and 5.0 × 10−2 copies/ml and blank control (distilled water). The LoD of plasmid template could be detected when the reaction lasted for 35 min (C). CL, control line; TL, test line.

References

    1. Adachi K., Nielsen-Saines K., Klausner J. D. (2016). Chlamydia trachomatis infection in pregnancy: the global challenge of preventing adverse pregnancy and infant outcomes in Sub-Saharan Africa and Asia. Biomed Res. Int. 2016, 1–21. 10.1155/2016/9315757 - DOI - PMC - PubMed
    1. Anfossi L., Di Nardo F., Cavalera S., Giovannoli C., Baggiani C. (2019). Multiplex lateral flow immunoassay: an overview of strategies towards high-throughput point-of-need testing. Biosensors 9, 2. 10.3390/bios9010002 - DOI - PMC - PubMed
    1. Augustine R., Hasan A., Das S., Ahmed R., Mori Y., Notomi T., et al. (2020). Loop-mediated isothermal amplification (LAMP): a rapid, sensitive, specific, and cost-effective point-of-care test for coronaviruses in the context of COVID-19 pandemic. Biology 9, 182. 10.3390/biology9080182 - DOI - PMC - PubMed
    1. Avendaño C., Patarroyo M. A. (2020). Loop-mediated isothermal amplification as point-of-care diagnosis for neglected parasitic infections. Int. J. Mol. Sci. 21, 7981. 10.3390/ijms21217981 - DOI - PMC - PubMed
    1. Caven L., Carabeo R. A. (2020). Pathogenic puppetry: manipulation of the host actin cytoskeleton by Chlamydia trachomatis. Int. J. Mol. Sci. 21, 90. 10.3390/ijms21010090 - DOI - PMC - PubMed

LinkOut - more resources